Skip to main content

Synthesis, Purification, and Characterization of Oligoribonucleotides that Act as Agonists of TLR7 and/or TLR8

  • Protocol
  • First Online:
Therapeutic Oligonucleotides

Part of the book series: Methods in Molecular Biology ((MIMB,volume 764))

Abstract

Viral single-stranded (ss) RNA is the natural ligand for TLR7 and TLR8. Synthetic ssRNA has been shown to act as a ligand for TLR7 and TLR8. We have previously reported a novel RNA structure, referred to as stabilized immune modulatory RNA (SIMRA), in which two short phosphorothioate oligoribonucleotides were linked through their 3′-ends via a linker. SIMRA compounds had greater stability in serum than unmodified ssRNA and induced immune responses via TLR7 and/or TLR8. SIMRA compounds were synthesized using phosphoramidite chemistry on controlled-pore glass solid support derivatized with a linker. After cleavage from the solid support and removal of protecting groups, SIMRA compounds were purified on an anion-exchange HPLC followed by desalting/dialysis, and lyophilization. SIMRA compounds were characterized for their purity and sequence integrity by anion-exchange HPLC, capillary gel electrophoresis, polyacrylamide gel electrophoresis, and MALDI-TOF mass spectrophotometric analysis. As SIMRA compounds induce TLR7- and/or TLR8-mediated Th1-type immune responses, they have potential utility as therapeutic agents for a broad range of diseases, including cancer, infectious diseases, asthma, and allergies, and as adjuvants with vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Akira, S., Takeda, K., and Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2, 675–680.

    Article  PubMed  CAS  Google Scholar 

  2. Pandey, S., and Agrawal, D. K. (2006) Immunobiology of toll-like receptors: emerging trends. Immunol Cell Biol 84, 333–341.

    Article  PubMed  CAS  Google Scholar 

  3. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C. (2004) Innate viral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529–1531.

    Article  PubMed  CAS  Google Scholar 

  4. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., and Bauer, S. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526–1529.

    Article  PubMed  CAS  Google Scholar 

  5. Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., and Flavell, R. A. (2004) Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 101, 5598–5603.

    Article  PubMed  CAS  Google Scholar 

  6. Chuang, T. H., and Ulevitch, R. J. (2000) Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8, and hTLR9. Eur Cytokine Netw 11, 372–378.

    PubMed  CAS  Google Scholar 

  7. Iwasaki, A., and Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 10, 987–995.

    Article  Google Scholar 

  8. Lee, J., Chuang, T. H., Redecke, V., She, L., Pitha, P. M., Carson, D. A., Raz, E., and Cottam, H. B. (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 100, 6646–6651.

    Article  PubMed  CAS  Google Scholar 

  9. Dow, S. (2008) Liposome–nucleic acid immunotherapeutics. Expert Opin Drug Deliv 5, 11–24.

    Article  PubMed  CAS  Google Scholar 

  10. Forsbach, A., Nemorin, J. G., Montino, C., Müller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G. K., Krieg, A. M., Lipford, G. B., and Vollmer, J. (2008) Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol 180, 3729–3738.

    PubMed  CAS  Google Scholar 

  11. Agrawal, S., and Kandimalla, E. R. (2007) Synthetic agonists of toll-like receptors 7, 8, and 9. Biochem Soc Trans 35, 1461–1467.

    Article  PubMed  CAS  Google Scholar 

  12. Lan, T., Kandimalla, E. R., Yu, D., Bhagat, L., Li, Y., Wang, D., Zhu, F., Tang, J. X., Putta, M. R., Cong, Y., Trombino, A. F., Sullivan, T., and Agrawal, S. (2007) Stabilized immune modulatory RNA compounds as agonists of toll-like receptors 7 and 8. Proc Natl Acad Sci USA 104, 13750–13755.

    Article  PubMed  CAS  Google Scholar 

  13. Lan, T., Dai, M., Wang, D., Zhu, F., Kandimalla, E. R., and Agrawal, S. (2009) Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies. J Med Chem 52, 6871–6879.

    Article  PubMed  CAS  Google Scholar 

  14. Lan, T., Bhagat, L., Wang, D., Dai, M., Kandimalla, E. R., and Agrawal, S. (2009) Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8. Bioorg Med Chem Lett 19, 2044–2047.

    Article  PubMed  CAS  Google Scholar 

  15. Lan, T., Putta, M. R., Wang, D., Dai, M., Yu, D., Kandimalla, E. R., and Agrawal, S. (2009) Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8. Biochem Biophys Res Commun 386, 443–448.

    Article  PubMed  CAS  Google Scholar 

  16. Beaucage, S. L., and Caruthers, M. H. (1981) Deoxynucleotide phosphoramidites – a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett 22, 1859–1862.

    Article  CAS  Google Scholar 

  17. Iyer, R. P., Egan, W., Regan, J. B., and Beaucage, S. L. (1990) 3H-1,2-Benzodithiole-3-one-1,1-dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphorothioates. J Am Chem Soc 112, 1253–1254.

    Article  CAS  Google Scholar 

  18. Puglisi, J. D., and Tinoco, I. Jr. (1989) Absorbance melting curves of RNA. Methods Enzymol 180, 304–325.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Sudhir Agrawal for support, encouragement, and suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ekambar R. Kandimalla .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Lan, T., Kandimalla, E.R. (2011). Synthesis, Purification, and Characterization of Oligoribonucleotides that Act as Agonists of TLR7 and/or TLR8. In: Goodchild, J. (eds) Therapeutic Oligonucleotides. Methods in Molecular Biology, vol 764. Humana Press. https://doi.org/10.1007/978-1-61779-188-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-188-8_17

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-187-1

  • Online ISBN: 978-1-61779-188-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics